Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor Types

Clinical trial NCT06782412 · RECRUITING

Trial details

NCT number: NCT06782412
Sponsor: KU Leuven
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Oesophageal Cancer Gastric Cancer Pancreatic Ductal Adenocarcinoma FAP Oncology Oncologic Disorders

Start date: 2025-02-06
Primary completion: 2027-12-01
Enrollment: 109

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.